VERISIM LIFE, INC.
Biotech · Private
AI-driven drug discovery platform (BIOiSIM) that predicts pharmacokinetics, pharmacodynamics, and toxicity profiles of drug candidates using physiologically-based computational modeling and machine le
verisimlife.com →- Grants
- $1.7M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Rapid repurposing and translation of COVID-19 therapeutics using a AI-based biosimulation platform: application to ACE2 and Ca2+ multi-target therapies (COVID-19) | $255,908 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity | $312,310 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity | $312,310 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of therapeutic candidates for stimulant use disorder using AI-driven platform for focused drug discovery and accelerated development | $811,876 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1146 | RAZI PHARMA LLC | — | — |
| 1147 | Character Bio | — | — |
| 1148 | Vulcan Biologics, Inc. | — | — |
| 1149 | VERISIM LIFE, INC. | — | — |
| 1150 | PAFOSPHARMA, LLC | — | — |
| 1151 | Adaptive Phage Therapeutics, Inc. | — | $45M |
| 1152 | SERION, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Systems And Methods For Full Body Circulation And Drug Concentration Predictiongranted
- Systems And Methods For Full Body Circulation And Drug Concentration Predictionapplication
- Systems And Methods For Full Body Circulation And Drug Concentration Predictionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.